Random good picture Not show

(1) Little is known, however, about plasminogen activators in solid tumours of the upper gastrointestinal tract.

(2) The concentrations of urokinase type plasminogen activator in the duodenum resemble the quantities found in normal stomach tissue biopsy specimens.

(3) For urokinase type plasminogen activator antigen in the stomach the opposite was observed.

(4) In summary, several approaches have produced engineered plasminogen activators with an increased thrombolytic potency in experimental animal models.

(5) The tissue type plasminogen activator antigen concentrations in both oesophageal carcinomas and stomach carcinomas were similar to those of the normal tissues.

(6) In the presence of fibrin, tissue type plasminogen activator converts plasminogen to plasmin, which subsequently cleaves the chromogenic substrate.

(7) The significantly lower plasminogen activator activity of malignant ascites is associated with greatly increased concentrations of plasminogen activator inhibitor-1.

(8) And he adds that trace levels of plasminogen would have been present in the products made from the infected donor's blood.

(9) Our results confirm that alcoholic ascites contains plasminogen activating activity.

(10) Murine monoclonal antibodies conjugated with plasminogen activators may be valuable for targeting the therapeutic agent to thrombus.

(11) In the present study tissue type plasminogen activator activity in columnar carcinomas of the stomach, however, was significantly decreased.

(12) Plasminogen activator ( PA ) and plasminogen activator inhibitor ( PAI ) are involved in many physiological or pathological events.

(13) Objective To investigate the plasma tissue-type plasminogen activator(t-PA) and plasminogen activator inhibitor(PAI) in coronary heart disease patients with angina pectoris and its probable mechanism.

(14) NIHSS scores were determined before tissue plasminogen activator bolus and at 60 and 120 minutes in both data sets.

(15) Reteplase is a part of human tissue-type plasminogen . It is expressed in Escherichia Coli cells.

(16) Objective To investigate the relationship between the plasminogen activator inhibitor 1(PAI 1) promotor region gene polymorphism and cerebral stroke.

(17) Improved thrombolytic therapy will most likely consist of potent specific plasminogen activators in combination with targeted anticoagulant and/or antiplatelet agents.

(18) Neither study, however, directly measured the ascitic concentrations of tissue plasminogen activator.

(19) The amount of colour developed during a fixed time is proportional to the tissue type plasminogen activator activity in the sample.

(20) These results could suggest a prominent role of tissue type plasminogen activator in the pathogenesis of endothelin induced gastric mucosal damage.

(21) Fibrinolytic activity was determined by a balance between tissue plasminogen activator and plasminogen activator inhibitor-1.

(22) These results give rise to the hypothesis that endothelin might increase the tissue type plasminogen activator activity accompanying the gastric mucosal injury.

(23) We studied the mechanism of plasma and tissue kallikrein in activating plasminogen.

(24) Objective To construct an expression vector for highly efficient expression of tissue-type plasminogen activator (t-PA) confined in the mammary gland of cow to develop a cow mammary gland bioreactor.

(25) The appearance of serine proteases such as thrombin(sentencedict.com), tissue plasminogen activator and plasmin in the CNS have come under increasing scrutiny.

(26) Maybe liver softening-Granules treated hepatic fibrosis by regulating the plasminogen activator system and hasten the fibrin dissolve.

(27) Recently, a lot of studies have been demonstrated that SPC increased cell migration and induced the expression of plasminogen activator related to cell migration.

(28) Lysis of the hematoma with various enzymes, such as urokinase or tissue plasminogen activator (TPA), and drainage of liquefied clot has become an alternative.

(29) But Dr. Marian LaMonte, co-director of the Brain Attack Team, began intravenously administering a drug called tissue plasminogen activator (t-PA).

(30) Objective To investigate effects of two proinflammatory cytokines on the production of plasminogen activator inhibitor 1(PAI 1) by human pleural mesothelial cells(HPMC).